District Of Columbia § 48-844.03 - Evaluation.
Full text of District Of Columbia D.C. Code § 48-844.03 — Evaluation., with citation guidance and answers to common questions.
§ 48-844.03. Evaluation.
48-844.03Within 60 days of September 30, 2010, the Department of Health shall submit to the Council a comprehensive evaluation on the effectiveness of the SafeRx Amendment Act of 2008, effective March 26, 2008 (), which shall include:
The number of individuals licensed to engage in the practice of pharmaceutical detailing since March 26, 2008;
The number of applicants for licensure to engage in the practice of pharmaceutical detailing not approved by the Board of Pharmacy;
The number of applicants for licensure to engage in the practice of pharmaceutical detailing for whom the educational requirements were waived;
An assessment of the appropriateness and efficacy of the continuing education requirements established pursuant to ;
The number of individuals identified as engaging in the practice of pharmaceutical detailing without a license;
The amount of fines levied against persons charged with engaging in the practice of pharmaceutical detailing without a license;
The total amount and origin of revenue deposited into the Board of Pharmacy Fund;
The total amount of funds deposited into the Board of Pharmacy Fund that were used for the administration of the duties of the Board of Pharmacy;
The number and types of penalties levied for failure to comply with the requirements of off-label use of medication as set forth in ;
The number and amount of fines levied for violations as a result of pharmaceutical companies offering gifts or remuneration in violation of ;
The number of persons who participated in the Pharmaceutical Education Program established by ;
An assessment of the quality and effectiveness of the Pharmaceutical Education Program based on an assessment of data gathered from those who participated in the program. The data may be gathered by surveying those who participated in the program, using an evaluative instrument developed for that purpose;
An assessment of the extent to which regulation of the practice of pharmaceutical detailing has improved the practice of selling, providing information about, or promoting a pharmaceutical product.
The evaluation may be used to determine if should be repealed or amended.
Annotations
Source: official District Of Columbia text · Last verified 2026-08-27
Frequently Asked Questions About District Of Columbia § 48-844.03
What does D.C. Code § 48-844.03 cover?
Section 48-844.03 ("Evaluation.") is part of the D.C. Code, the codified statutory law of District Of Columbia. It sets out the legal rule or procedure described in the text above. Statutes are amended regularly, so always verify against the official source.
How do I cite District Of Columbia § 48-844.03?
A common citation format is "D.C. Code § 48-844.03" (District Of Columbia). Legal writing may require the code abbreviation, section number, and year or edition. Match the style required by your court, professor, or publisher.
Is this the official text of District Of Columbia law?
No. This page is for research and education and may not include the most recent amendments. For official current law, check the District Of Columbia official source linked on this page or consult a licensed District Of Columbia attorney.
How does District Of Columbia § 48-844.03 apply to my situation?
Statutes are interpreted in context, and application depends on your specific facts. Only a licensed attorney in District Of Columbia can advise on how this section applies to you. Contact your state or local bar association for a referral.
Sources & Verification
Not legal advice. Verify against the official source and consult a licensed attorney in District Of Columbia.